Taken together, we have shown that Andrographolide is an effective anti-cancer compound for prostate cancer by regulating genes associated to double-strand breaks such as ATM, NBN, BRCA2 BLM, PALB2 and BLM. Here, BLM is linked to prostate carcinoma.